Generated by AI
Axogen, Inc. is a medical technology company focused on peripheral nerve regeneration and repair. Axogen develops and commercializes surgical solutions used by surgeons and healthcare providers to address nerve injuries caused by trauma, procedures, or disease. Its current product portfolio includes nerve allografts, nerve connectors, nerve protectors, nerve caps, and soft tissue membranes designed to support nerve reconstruction, protection, and functional restoration. The company serves hospitals, surgery centers, military hospitals, and specialists in reconstructive, hand, orthopedic, plastic, and oral and maxillofacial surgery. Axogen plays a specialized role in the medical devices market by offering targeted technologies for peripheral nerve care and by supporting clinical education around surgical treatment of nerve damage. Headquartered in Alachua, Florida, Axogen remains focused on a niche segment of regenerative medicine and surgical reconstruction.
Website13631 Progress Boulevard
Alachua, FL, 32615
United States
The latest articles about AXGN.
Axogen has delivered a very large 3 year return, which puts a bright spotlight on what investors are really paying for in terms of future cash generation. With the share price recently closing at US$58.63, the question now is how that move lines up with the cash flows the business may realistically produce over time. The stock has returned roughly 9x over the past 3 years, which makes the link between Axogen's current valuation and its cash flow profile especially important for anyone...
Summary of Oct 28's posts. Generated by AI.
Summary of Oct 28's posts. Generated by AI.
Summary of Oct 28's posts. Generated by AI.
Investors talking about AXGN also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.